Profiling of tumour-associated microbiota in human hepatocellular carcinoma
暂无分享,去创建一个
[1] Erratum: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. , 2020, CA: a cancer journal for clinicians.
[2] Noam Shental,et al. The human tumor microbiome is composed of tumor type–specific intracellular bacteria , 2020, Science.
[3] Q. Ou,et al. Gut microbiota dysbiosis in patients with hepatitis B virus–induced chronic liver disease covering chronic hepatitis, liver cirrhosis and hepatocellular carcinoma , 2020, Journal of viral hepatitis.
[4] R. Bataller,et al. Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease , 2019, Nature.
[5] Chenchen Xie,et al. Hepatocellular carcinoma in alcoholic and non-alcoholic fatty liver disease-one of a kind or two different enemies? , 2019, Translational gastroenterology and hepatology.
[6] Christine B. Peterson,et al. Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes , 2019, Cell.
[7] H. Vlamakis,et al. Ruminococcus gnavus, a member of the human gut microbiome associated with Crohn’s disease, produces an inflammatory polysaccharide , 2019, Proceedings of the National Academy of Sciences.
[8] Yewei Zhang,et al. Alteration in gut microbiota associated with hepatitis B and non-hepatitis virus related hepatocellular carcinoma , 2019, Gut Pathogens.
[9] Lixin Wei,et al. Tumor necrosis factor-α promotes hepatocellular carcinogenesis through the activation of hepatic progenitor cells. , 2018, Cancer letters.
[10] A. Jemal,et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.
[11] H. Yoshiji,et al. Gut Dysbiosis Associated With Hepatitis C Virus Infection , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[12] Eric C. Polley,et al. Interaction between the microbiome and TP53 in human lung cancer , 2018, Genome Biology.
[13] A. Gasbarrini,et al. Hepatocellular Carcinoma Is Associated With Gut Microbiota Profile and Inflammation in Nonalcoholic Fatty Liver Disease , 2018, Hepatology.
[14] Tian Tian,et al. Distinct Microbial Signatures Associated With Different Breast Cancer Types , 2018, Front. Microbiol..
[15] Justine W. Debelius,et al. The gut–liver axis and the intersection with the microbiome , 2018, Nature Reviews Gastroenterology & Hepatology.
[16] Donna Neuberg,et al. Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer , 2017, Science.
[17] Menghui Zhang,et al. Gut Microbial Dysbiosis Is Associated with Altered Hepatic Functions and Serum Metabolites in Chronic Hepatitis B Patients , 2017, Front. Microbiol..
[18] Pelin Yilmaz,et al. 25 years of serving the community with ribosomal RNA gene reference databases and tools. , 2017, Journal of biotechnology.
[19] M. Yassour,et al. A novel Ruminococcus gnavus clade enriched in inflammatory bowel disease patients , 2017, Genome Medicine.
[20] Noam Shental,et al. Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine , 2017, Science.
[21] R. Schwabe,et al. The gut microbiome and liver cancer: mechanisms and clinical translation , 2017, Nature Reviews Gastroenterology &Hepatology.
[22] Shibu Yooseph,et al. Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease. , 2017, Cell metabolism.
[23] Zhi Wei,et al. The ovarian cancer oncobiome , 2017, Oncotarget.
[24] G. Gloor,et al. The Microbiota of Breast Tissue and Its Association with Breast Cancer , 2016, Applied and Environmental Microbiology.
[25] Lawrence A. David,et al. The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota , 2016, Hepatology.
[26] K. Hayashi,et al. DSS colitis promotes tumorigenesis and fibrogenesis in a choline-deficient high-fat diet-induced NASH mouse model. , 2016, Biochemical and biophysical research communications.
[27] Jean M. Macklaim,et al. Microbiota of Human Breast Tissue , 2014, Applied and Environmental Microbiology.
[28] Pelin Yilmaz,et al. The SILVA and “All-species Living Tree Project (LTP)” taxonomic frameworks , 2013, Nucleic Acids Res..
[29] M. Meyerson,et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. , 2013, Cell host & microbe.
[30] Pelin Yilmaz,et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools , 2012, Nucleic Acids Res..
[31] H. El‐Serag,et al. Epidemiology of viral hepatitis and hepatocellular carcinoma. , 2012, Gastroenterology.
[32] Raul Rabadan,et al. Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4. , 2012, Cancer cell.
[33] C. Huttenhower,et al. Metagenomic biomarker discovery and explanation , 2011, Genome Biology.
[34] P. Bork,et al. Enterotypes of the human gut microbiome , 2011, Nature.
[35] Anders F. Andersson,et al. A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. , 2010, Gastroenterology.
[36] Guan-Tarn Huang,et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. , 2006, JAMA.
[37] S. D. Lee,et al. Endotoxemia in patients with chronic liver diseases: relationship to severity of liver diseases, presence of esophageal varices, and hyperdynamic circulation. , 1995, Journal of hepatology.
[38] S. Orsulic,et al. Ovarian Cancer , 1993, British Journal of Cancer.
[39] M. Kawahara,et al. Analysis of endoscopic brush samples identified mucosa-associated dysbiosis in inflammatory bowel disease , 2017, Journal of Gastroenterology.
[40] F. Bishehsari,et al. Alcohol and Gut-Derived Inflammation , 2017, Alcohol research : current reviews.
[41] P. Loehrer,et al. Risk of Hepatocellular Carcinoma Across a Biological Gradient of Serum Hepatitis B Virus DNA Level , 2007 .